FDA grants breakthrough status to Grin Therapeutics’ radiprodil
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Grin Therapeutics’ radiprodil.
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Grin Therapeutics’ radiprodil.
What's Your Reaction?
